Microsure B.V.

Microsure B.V. specializes in robotic systems tailored for microsurgical procedures. Their portfolio includes the MUSA-3 Microsurgical Robot System and the MSR-Gen 2, both designed to assist in delicate surgeries like laser-assisted vascular anastomosis (LVA), free flap reconstruction, and nerve repair. These devices leverage precision robotics to enhance surgical accuracy in minimally invasive contexts.

Microsure B.V. is headquartered in the Netherlands, which places its devices under the regulatory framework of the European Union. Since their products fall under EU Device Class IIa—requiring conformity assessment but not full clinical evaluation—they must comply with EU Medical Device Regulations (MDR) or MDD, depending on the applicable timeline. This classification also means their devices are listed in the EU’s official database, eudamed, for transparency and traceability.

Yes, Microsure B.V.’s devices are registered in eudamed, the EU’s central database for medical devices. This listing is critical because it ensures visibility for healthcare providers, regulators, and authorities when verifying device compliance with EU requirements. For Class IIa devices like those from Microsure, eudamed inclusion confirms they meet mandatory EU standards, including risk management and technical documentation, before entering the market.

Microsure B.V.’s devices are classified as EU Class IIa, which indicates a moderate risk level requiring conformity assessment (e.g., design examination by a Notified Body) but not full clinical trials. This classification reflects their role in precision microsurgery, where accuracy is critical but the inherent risks are manageable with proper validation. Class IIa devices must still comply with EU MDR/MDD requirements, including labeling, post-market surveillance, and traceability, ensuring patient safety while streamlining regulatory oversight compared to higher-risk classes.